Cytonics on SeedInvest

Relief for Osteoarthritis

CLOSED

see other companies in category:

visit:
Cytonics Website

minimum raise

$25,000

maximum raise

$1,000,000

start date

04/05/2019

stop date

05/18/2019

security type

Convertible Note

investment minimum

$1,000

raised to date

$429,344

reporting date

CLOSED

number of investors

Not Known

percent of minimum raised

1,717%

percent of maximum raised

43%

likelihood of reaching max

Likely to Reach Max

dollars per day to reach max

$0

dollars per day committed

$9,985

dollars per day - category-

$2,802

dollars per day committed - all companies

$1,080
More SEC Filing Data on Cytonics from Crowdfilings.com

Cytonics, with a valuation cap of $32.4 million, is raising Series C funding on SeedInvest. The company is a leader in regenerative medicine and has developed innovative therapies for musculoskeletal diseases like osteoarthritis. Cytonics has created an Autologous Platelet Integrated Concentration system that concentrates A2M from patients’ blood to treat their own damaged joints. Cytonics was founded by Gaetano Scuderi, a leading orthopedic surgeon with over 21 years of experience. The company has already raised $15 million in previous rounds of funding and the current crowdfunding round has a round size of $1 million. Cytonics has received $1.8 million in government grants from the NIH and has 6 issued and 9 pending patents.